1,25 dihydroxyvitamin D3 limits monocyte maturation in lupus sera

Area of Science:

• Immunology
• Endocrinology
• Cell Biology

Background:

• Antigen-presenting cells (APCs) are crucial for initiating immune responses.
• Vitamin D metabolites, particularly 1,25-dihydroxyvitaminD(3) (1,25(OH)(2)D(3)), are known immunomodulators.
• Dysregulated APC function is implicated in autoimmune diseases like systemic lupus erythematosus (SLE).

Purpose of the Study:

• To investigate the effect of 1,25(OH)(2)D(3) on human APC maturation in vitro.
• To determine if 1,25(OH)(2)D(3) modulates APC responses under various cytokine conditions and in the presence of SLE sera.

Main Methods:

• Human monocytes were isolated and cultured with sera (from SLE patients and healthy volunteers) with or without 1,25(OH)(2)D(3).
• Cells were stimulated with interferon-alpha (IFNα), granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin-4 (IL-4), or cultured without cytokines.
• Expression of APC surface markers (MHC Class II, CD40, CD86, CD14) was analyzed.

Main Results:

• 1,25(OH)(2)D(3) limited the expression of maturation markers (MHC Class II, CD40, CD86) and increased CD14 expression on monocytes.
• These inhibitory effects were observed irrespective of stimulation with IFNα, GM-CSF/IL-4, or serum alone.
• 1,25(OH)(2)D(3) significantly inhibited APC activation induced by SLE sera, suggesting interference with soluble mediators.

Conclusions:

• 1,25(OH)(2)D(3) suppresses human APC activation through IFNα-dependent and independent pathways.
• The vitamin D metabolite demonstrates potential to mitigate the immunostimulatory milieu in SLE by targeting cytokine mediators in patient sera.